Differential impact of belatacept and cyclosporine A on central aortic blood pressure and arterial stiffness after renal transplantation

Clinical Transplantation

Volumn 28, Issue 9, 2014, Pages 1004-1009

  Seibert, Felix S ^a,b   Steltzer, Julia ^b   Melilli, Eduardo ^c   Grannas, Gerrit ^d   Pagonas, Nikolaos ^a,b   Bauer, Frederic ^a,b   Zidek, Walter ^b   Grinyó, Josep ^c   Westhoff, Timm H ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Arterial stiffness; Augmentation pressure; Belatacept; Calcineurin inhibitor; Renal transplantation

Indexed keywords

BELATACEPT; CYCLOSPORIN A; MYCOPHENOLIC ACID; ABATACEPT; ANTIBODY CONJUGATE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; AORTA PRESSURE; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MULTICENTER STUDY; PULSE WAVE; SPHYGMOMANOMETER; SYSTOLIC BLOOD PRESSURE; ARTERIAL PRESSURE; BLOOD PRESSURE; DRUG EFFECTS; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; MIDDLE AGED; PROGNOSIS;

ARTERIAL PRESSURE; BLOOD PRESSURE; CASE-CONTROL STUDIES; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOCONJUGATES; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84908365947     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12413     Document Type: Article

References (32)

1. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int 2000: 57: 307.
2. Kasiske BL. Epidemiology of cardiovascular disease after renal transplantation. Transplantation 2001: 72(6 Suppl): S5.
3. Ferro CJ, Savage T, Pinder SJ, Tomson CR. Central aortic pressure augmentation in stable renal transplant recipients. Kidney Int 2002: 62: 166.
4. Zoungas S, Kerr PG, Chadban S et al. Arterial function after successful renal transplantation. Kidney Int 2004: 65: 1882.
5. Strozecki P, Adamowicz A, Wlodarczyk Z, Manitius J. Factors associated with increased arterial stiffness in renal transplant recipients. Med Sci Monit 2010: 16: CR301.
6. Hornum M, Clausen P, Idorn T, Hansen JM, Mathiesen ER, Feldt-Rasmussen B. Kidney transplantation improves arterial function measured by pulse wave analysis and endothelium-independent dilatation in uraemic patients despite deterioration of glucose metabolism. Nephrol Dial Transplant 2011: 26: 2370.
7. Vincenti F, Charpentier B, Vanrenterghem Y et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 2010: 10: 535.
8. Vanrenterghem Y, Bresnahan B, Campistol J et al. Belatacept-based regimens are associated with improved cardiovascular and metabolic risk factors compared with cyclosporine in kidney transplant recipients (BENEFIT and BENEFIT-EXT studies). Transplantation 2011: 91: 976.
9. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001: 38: 434.
10. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006: 113: 1213.
11. O'Rourke MF, Franklin SS. Arterial stiffness: reflections on the arterial pulse. Eur Heart J 2006: 27: 2497.
12. McEniery CM, Yasmin , Hall IR et al. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005: 46: 1753.
13. Laurent S, Boutouyrie P, Asmar R et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001: 37: 1236.
14. Westhoff TH, Straub-Hohenbleicher H, Basdorf M et al. Time-dependent effects of cadaveric renal transplantation on arterial compliance in patients with end-stage renal disease. Transplantation 2006: 81: 1410.
15. Westhoff TH, Schmidt S, Glander P et al. The impact of FTY720 (fingolimod) on vasodilatory function and arterial elasticity in renal transplant patients. Nephrol Dial Transplant 2007: 22: 2354.
16. Seibert F, Behrendt C, Schmidt S, van der Giet M, Zidek W, Westhoff TH. Differential effects of cyclosporine and tacrolimus on arterial function. Transpl Int 2011: 24: 708.
17. Agabiti-Rosei E, Mancia G, O'Rourke MF et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 2007: 50: 154.
18. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J 1993: 14: 160.
19. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001: 38: 932.
20. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009: 150: 604.
21. Kaur M, Chandran D, Lal C et al. Renal transplantation normalizes baroreflex sensitivity through improvement in central arterial stiffness. Nephrol Dial Transplant 2013: 28: 2645.
22. Covic A, Mardare N, Gusbeth-Tatomir P, Buhaescu I, Goldsmith DJ. Acute effect of CyA A (Neoral) on large artery hemodynamics in renal transplant patients. Kidney Int 2005: 67: 732.
23. Lanese DM, Conger JD. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 1993: 91: 2144.
24. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993: 92: 1859.
25. Ruggenenti P, Perico N, Mosconi L et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993: 43: 706.
26. Wolf A, Trendelenburg CF, Diez-Fernandez C et al. Cyclosporine A-induced oxidative stress in rat hepatocytes. J Pharmacol Exp Ther 1997: 280: 1328.
27. Scherrer U, Vissing SF, Morgan BJ et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990: 323: 693.
28. Prince CT, Secrest AM, Mackey RH, Arena VC, Kingsley LA, Orchard TJ. Augmentation pressure and subendocardial viability ratio are associated with microalbuminuria and with poor renal function in type 1 diabetes. Diab Vasc Dis Res 2010: 7: 216.
29. Safar ME, Blacher J, Pannier B et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002: 39: 735.
30. Brooks B, Molyneaux L, Yue DK. Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care 1999: 22: 1722.
31. Brooks BA, Molyneaux LM, Yue DK. Augmentation of central arterial pressure in type 2 diabetes. Diabet Med 2001: 18: 374.
32. Chirinos JA, Zambrano JP, Chakko S et al. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 2005: 45: 980.